Drug Profile
Hib-DTP vaccine - Zydus Lifesciences
Alternative Names: Diphtheria-tetanus-haemophilus infections-whole cell pertussis vaccine - Zydus LifesciencesLatest Information Update: 21 Mar 2022
Price :
$50
*
At a glance
- Originator Cadila Healthcare
- Developer Zydus Lifesciences
- Class Bacterial vaccines; Conjugate vaccines; Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diphtheria; Haemophilus infections; Pertussis; Tetanus
Most Recent Events
- 11 Mar 2021 Discontinued - Phase-I for Diphtheria (Prevention, In volunteers, In adults) in India (IM) (Zydus Cadila website, March 2021)
- 11 Mar 2021 Discontinued - Phase-I for Haemophilus infections (Prevention, In volunteers, In adults) in India (IM) (Zydus Cadila website, March 2021)
- 11 Mar 2021 Discontinued - Phase-I for Pertussis (Prevention, In volunteers, In adults) in India (IM) (Zydus Cadila website, March 2021)